Opioid Withdrawal clinical trials

Explore recruiting opioid withdrawal clinical trials.

Recruiting opioid withdrawal studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Opioid Withdrawal trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The dual orexin receptor antagonist daridorexant as an adjunct to improve buprenorphine maintenance therapy of opioid use disorder

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Opioid Withdrawal trials by city

Opioid Withdrawal in Toronto Opioid Withdrawal in Vancouver Opioid Withdrawal in Montreal Opioid Withdrawal in Calgary Opioid Withdrawal in Edmonton Opioid Withdrawal in Ottawa Opioid Withdrawal in Winnipeg Opioid Withdrawal in Quebec City Opioid Withdrawal in Hamilton Opioid Withdrawal in Kitchener Opioid Withdrawal in London Opioid Withdrawal in Halifax Opioid Withdrawal in New York Opioid Withdrawal in Los Angeles Opioid Withdrawal in Chicago Opioid Withdrawal in Houston

Opioid Withdrawal clinical trials

Recruiting opioid withdrawal studies right now

A Study to Train a Machine Learning Algorithm for an Evaluation of the Use of Biometric Data Captured at the Wrist for the Identification of Acute Opioid Use Events and the Quantification of Opioid Withdrawal in Opioid Dependent Individuals

Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3

Assessing a Clinically-meaningful Opioid Withdrawal Phenotype

ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain

Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal

Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder

Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal

Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)

Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms

Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder

Evaluating Buspirone to Treat Opioid Withdrawal

Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain

Also recruiting in Europe

The dual orexin receptor antagonist daridorexant as an adjunct to improve buprenorphine maintenance therapy of opioid use disorder

Opioid Withdrawal trials by city

Other conditions